Definitive Contract 75A50425C00001

Award Date 1/29/25
Potential Completion Date 7/14/25
Potential Value Not listed
Awardee
Osang LLC
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
South Pasadena, CA 91030, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
10
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $52,239,640.00 definitive contract awarded to Visby Medical, Inc. by the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response. The contract is for the delivery of a rapid, accurate, point-of-care disposable influenza and SARS-CoV-2 molecular diagnostic test. This award is not set aside for any particular business classification. The contract has an ultimate completion date of March 31, 2026. The original solicitation was issued...
This is a $38,900,000.00 firm fixed-price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Hologic, Inc. to ensure test availability for SARS-CoV-2 after the emergency authorization closes. The purpose is for Hologic to submit an in vitro diagnostic (IVD) assay for SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV) by September 30, 2027. This contract was awarded under a Broad Agency Announcement (BAA)...
This $34,714,763.00 cost-plus-fixed-fee contract was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Detect Inc. to advance the development of a second-generation, multi-analyte molecular SARS-CoV-2 and influenza A/B test that has a reduced time to result and increased sensitivity for use at home or in a point-of-care setting. The contract is not set aside. The award references a Broad Agency Announcement (BAA) issued by the Biomedical Advanced Research...
This is a $2,596,000.00 definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The purpose of this firm-fixed-price contract is to procure over-the-counter (OTC) COVID-19 tests. The contract has an ultimate completion date of February 15, 2023 and was awarded on December 7, 2022. No set-aside designation was used for...
This is a $81,200.00 firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) to Ars Sales & Services LLC, a woman-owned small disadvantaged business located in Minneola, Florida. The contract is for the delivery of 8 and 50 units of NSN 6550016878125 COVID-19 test kits, to be delivered to the Eisenhower Army Medical Center and the 18th Medical Support Squadron, respectively, within 5 days of the order. The original solicitation was a request for quotes (RFQ)...
This is a $257,060,695.20 firm-fixed-price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, for the procurement of over-the-counter (OTC) COVID-19 tests. The contract has a completion date of March 30, 2023 and does not utilize a set-aside designation. Abbott Rapid DX North America LLC is a major supplier of COVID-19 diagnostic products,...
This is a $748,027.21 firm fixed price contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Senzo, Inc. for the development of a high-sensitivity, home-based, over-the-counter COVID-19 rapid diagnostic test. The contract was awarded under AOI #11A of ASPR's Division of Research, Innovation, and Ventures (DRIVe) Easy Broad Agency Announcement (EZ-BAA), which focuses on home-based diagnostics for SARS-CoV-2 detection. The contract has a period of...
<p>The U.S. Department of Health and Human Services, through the Office of the Assistant Secretary for Preparedness and Response, has awarded a $4,500,000.00 firm-fixed-price definitive contract to Genabio Diagnostics Inc. for the provision of over-the-counter (OTC) COVID-19 tests. The contract, which is not set aside, has an ultimate completion date of March 19, 2025. This contract award appears to be a standalone acquisition and not part of a larger vehicle.</p>
<p>This is a $31,384,584.00 firm fixed price definitive contract awarded by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response to Kwell Laboratories LLC, a minority-owned small disadvantaged business, for the delivery of over-the-counter COVID-19 tests. The contract has an ultimate completion date of March 19, 2025. The contract is not set aside and was awarded on September 20, 2023.</p>
The Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response awarded a $7,048,087.00 firm fixed price contract to Orasure Technologies Inc. (doing business as Orasure) for the provision of INTELISWAB COVID-19 rapid tests. This contract was set aside exclusively for small businesses and has a period of performance through April 30, 2024. The original solicitation, issued by the Biomedical Advanced Research and Development Authority (BARDA)...

This is a $2,100,000.00 Firm Fixed Price (FFP) contract awarded by the U.S. Department of Health and Human Services (HHS), Administration for Strategic Preparedness and Response (ASPR), Center for Industrial Base Expansion and Supply Chain (IBMSC) to Osang LLC, a small disadvantaged business, for the delivery of 1,000,000 commercial off-the-shelf multi-antigen diagnostic test kits capable of detecting SARS-CoV-2 and Influenza A/B. The contract has a 12-month period of performance and is a 100% small business set-aside under NAICS code 325413 - In Vitro Diagnostic Substance Manufacturing. The purpose is to ensure the government is adequately prepared to rapidly respond to a spike in demand for these multi-antigen tests.

Generated 7/8/25, 2:32 PM